# Study to Evaluate the Safety and Efficacy of HLBLS-200 in Patients Requiring Hemostatic Technique

> **NCT03957356** · NA · COMPLETED · sponsor: **HLB Cell Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Hemorrhage

## Interventions

- **DEVICE:** HLBLS-200

## Key facts

- **NCT ID:** NCT03957356
- **Lead sponsor:** HLB Cell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-19
- **Primary completion:** 2020-03-02
- **Final completion:** 2020-07-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03957356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03957356, "Study to Evaluate the Safety and Efficacy of HLBLS-200 in Patients Requiring Hemostatic Technique". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03957356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*